These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2585271)

  • 1. Physical and structural comparison of oxyphenbutazone monohydrate and anhydrate.
    Stoltz M; Caira MR; Lotter AP; van der Watt JG
    J Pharm Sci; 1989 Sep; 78(9):758-63. PubMed ID: 2585271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical characterization of two oxyphenbutazone pseudopolymorphs.
    Stoltz M; Lötter AP; Van der Watt JG
    J Pharm Sci; 1988 Dec; 77(12):1047-9. PubMed ID: 3244109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical characterization of the methanol solvate of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1989 Jan; 78(1):28-34. PubMed ID: 2709315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization of erythromycin: anhydrate, monohydrate, and dihydrate crystalline solids.
    Allen PV; Rahn PD; Sarapu AC; Vanderwielen AJ
    J Pharm Sci; 1978 Aug; 67(8):1087-93. PubMed ID: 671242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates.
    van Tonder EC; Maleka TS; Liebenberg W; Song M; Wurster DE; de Villiers MM
    Int J Pharm; 2004 Jan; 269(2):417-32. PubMed ID: 14706253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical characterization of the hydrates of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1988 May; 77(5):444-51. PubMed ID: 3411469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterisation and dehydration behaviour of siramesine hydrochloride.
    Zimmermann A; Tian F; de Diego HL; Frydenvang K; Rantanen J; Elema MR; Hovgaard L
    J Pharm Sci; 2009 Oct; 98(10):3596-607. PubMed ID: 19156865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
    Bacchi A; Mori G; Pelizzi G; Pelosi G; Nebuloni M; Panzone GB
    Mol Pharmacol; 1995 Mar; 47(3):611-23. PubMed ID: 7700258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state properties and relationship between anhydrate and monohydrate of baclofen.
    Mirza S; Miroshnyk I; Rantanen J; Aaltonen J; Harjula P; Kiljunen E; Heinämäki J; Yliruusi J
    J Pharm Sci; 2007 Sep; 96(9):2399-408. PubMed ID: 17549770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine.
    Lowes MM; Caira MR; Lötter AP; Van der Watt JG
    J Pharm Sci; 1987 Sep; 76(9):744-52. PubMed ID: 11002813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of the various solid forms of carbovir, an antiviral nucleoside.
    Nguyen NA; Ghosh S; Gatlin LA; Grant DJ
    J Pharm Sci; 1994 Aug; 83(8):1116-23. PubMed ID: 7983595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and Interconversion of Two Crystal Forms of NEt-3IB, a Retinoid X Receptor Agonist.
    Takamura Y; Kikuzawa S; Fujihara M; Sunatsuki Y; Higaki K; Kakuta H
    Chem Pharm Bull (Tokyo); 2023; 71(4):282-288. PubMed ID: 37005253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roller compaction of different pseudopolymorphic forms of theophylline: Effect on compressibility and tablet properties.
    Hadzović E; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Aug; 396(1-2):53-62. PubMed ID: 20600735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal behaviour and stability in Olanzapine.
    Polla GI; Vega DR; Lanza H; Tombari DG; Baggio R; Ayala AP; Filho JM; Fernández D; Leyva G; Dartayet G
    Int J Pharm; 2005 Sep; 301(1-2):33-40. PubMed ID: 16040214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.
    Grzesiak AL; Lang M; Kim K; Matzger AJ
    J Pharm Sci; 2003 Nov; 92(11):2260-71. PubMed ID: 14603511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical characterization of solid iopanoic acid forms.
    Stagner WC; Guillory JK
    J Pharm Sci; 1979 Aug; 68(8):1005-9. PubMed ID: 480153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pulverization on hydration kinetic behaviors of creatine anhydrate powders.
    Sakata Y; Shiraishi S; Otsuka M
    Colloids Surf B Biointerfaces; 2004 Dec; 39(4):187-93. PubMed ID: 15555902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.